SEATTLE--(BUSINESS WIRE)--LifeSpan BioSciences, Inc., today announced an initiative to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years. The leader in immunohistochemistry (IHC) antibody validation research since 1995, LifeSpan expanded its product focus to include the development and sale of IHC-validated antibodies in Q4 2006. To date, LifeSpan has built a catalog of more than 37,000 reagent antibodies, including more than 2,000 antibodies validated for use in immunohistochemistry. The company intends to expand its IHC-validated reagent antibody catalog at the rate of 5,000 per year.
